M Toi Selected Research

M Toi Research Topics

Disease

56	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2000
40	Neoplasms (Cancer) 12/2022 - 01/2000
7	Neoplasm Metastasis (Metastasis) 04/2009 - 01/2000
6	Carcinoma (Carcinomatosis) 07/2005 - 04/2001
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2005 - 05/2001
3	Disease Progression 05/2024 - 01/2001
2	Residual Neoplasm 01/2017 - 08/2000
2	Pain (Aches) 09/2012 - 04/2001
2	Adenocarcinoma 07/2005 - 04/2001
2	Carcinoid Tumor (Carcinoid) 01/2005 - 04/2001
2	Fibrosis (Cirrhosis) 01/2005 - 01/2000
2	Oxyphilic Adenoma (Oncocytoma) 12/2001 - 10/2001
2	Hepatocellular Carcinoma (Hepatoma) 07/2001 - 07/2000
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2001 - 07/2000
1	Cytopenia 01/2022
1	Febrile Neutropenia 12/2017
1	Triple Negative Breast Neoplasms 04/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Margins of Excision 08/2016
1	Colorectal Neoplasms (Colorectal Cancer) 11/2011
1	Hand-Foot Syndrome 11/2011
1	Erythema 11/2011
1	Brain Neoplasms (Brain Tumor) 11/2009
1	Breast Carcinoma In Situ 01/2009
1	Hyperplasia 01/2009
1	Neutropenia 05/2008
1	Peptic Ulcer (Peptic Ulcers) 01/2006
1	Endometrial Neoplasms (Endometrial Cancer) 10/2005

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 12/2022 - 07/2000
9	Docetaxel (Taxotere)FDA Link 12/2017 - 06/2001
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2006 - 08/2000
6	Trastuzumab (Herceptin)FDA Link 07/2018 - 01/2001
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 06/2004
6	EnzymesIBA 10/2005 - 01/2000
6	Proteins (Proteins, Gene)FDA Link 02/2005 - 07/2000
5	Aromatase InhibitorsIBA 05/2024 - 01/2000
5	Epirubicin (Ellence)FDA LinkGeneric 08/2014 - 06/2004
5	Capecitabine (Xeloda)FDA Link 08/2014 - 04/2000
5	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2006 - 10/2002
5	Thymidine PhosphorylaseIBA 06/2004 - 07/2000
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2018 - 12/2001
4	Lapatinib (GW572016)FDA Link 07/2018 - 11/2009
4	Fluorouracil (Carac)FDA LinkGeneric 08/2014 - 06/2004
4	Messenger RNA (mRNA)IBA 01/2005 - 05/2000
3	abemaciclibIBA 05/2024 - 12/2021
3	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2001
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 04/2001
3	Tamoxifen FDA LinkGeneric 01/2009 - 01/2001
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2006 - 10/2005
3	Keratins (Keratin)IBA 01/2006 - 01/2004
3	Celecoxib (Celebrex)FDA Link 10/2005 - 10/2005
3	Estrogen ReceptorsIBA 07/2005 - 01/2000
3	Capsules (Microcapsules)IBA 01/2005 - 12/2002
3	beta CateninIBA 05/2001 - 11/2000
2	Fulvestrant (Faslodex)FDA Link 05/2024 - 06/2017
2	Bevacizumab (Avastin)FDA Link 04/2017 - 11/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2006 - 10/2005
2	Carcinoembryonic AntigenIBA 07/2005 - 04/2001
2	Indicators and Reagents (Reagents)IBA 01/2004 - 08/2000
2	ImmunosorbentsIBA 04/2003 - 07/2000
2	Monoclonal AntibodiesIBA 05/2002 - 01/2001
2	DNA (Deoxyribonucleic Acid)IBA 07/2001 - 04/2001
2	VimentinIBA 04/2001 - 05/2000
2	OsteonectinIBA 04/2001 - 05/2000
2	Phosphopyruvate Hydratase (Enolase)IBA 04/2001 - 05/2000
2	EndostatinsIBA 03/2001 - 01/2001
2	Estrogen Receptor alphaIBA 02/2001 - 05/2000
2	CytokinesIBA 08/2000 - 01/2000
2	Interleukin-4 (Interleukin 4)IBA 08/2000 - 01/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2000 - 01/2000
1	Poly Adenosine Diphosphate RiboseIBA 12/2022
1	olaparibIBA 12/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	HLA-DRB1*07 antigenIBA 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	Everolimus FDA Link 01/2016
1	Dihydrotachysterol (AT 10)IBA 09/2012
1	Phenobarbital (Luminal)FDA Link 07/2012
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2009
1	pegfilgrastim (Neulasta)FDA Link 05/2008
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2006
1	CAM 5.2 antigenIBA 01/2006
1	K-18 conjugate (K18)IBA 10/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2005
1	exemestane (Aromasin)FDA Link 10/2005
1	LipidsIBA 10/2005

Therapy/Procedure

29	Therapeutics 05/2024 - 01/2000
10	Drug Therapy (Chemotherapy) 07/2018 - 04/2001
7	Neoadjuvant Therapy 07/2018 - 01/2001
1	Time-to-Treatment 06/2017
1	Adjuvant Chemotherapy 04/2017
1	Segmental Mastectomy (Lumpectomy) 08/2016
1	Premedication 11/2011
1	Metastasectomy 04/2009
1	Chemoprevention 01/2009
1	Transplantation 10/2005